A452, HDAC6-selective inhibitor synergistically enhances the anticancer activity of immunomodulatory drugs in IMiDs-resistant multiple myeloma

Go Woon Kim, Jung Yoo, Hye Rim Won, Soo Keun Yeon, Sang Woo Lee, Dong Hoon Lee, Yu Hyun Jeon, So Hee Kwon

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A452, HDAC6-selective inhibitor synergistically enhances the anticancer activity of immunomodulatory drugs in IMiDs-resistant multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences